RMD News: Strategic Collaborations Aid QGEN Stock Amid Competition - 18th Jan 2025, 2:37am

[annb0t]

QIAGEN’s QGEN business is expected to get a boost from its growing molecular diagnostic market, expanded test menu and growth-driving strategic collaborations. Yet, a challenging macro environment and an intense competitive market may dent its results of operations. The stock carries a Zacks Rank #3 (Hold) currently.

Factors Driving Growth for QGEN Stock

QIAGEN offers one of the broadest portfolios of molecular technologies for healthcare. The range of assays for diseases and biomarkers s...

>>> Read more: Strategic Collaborations Aid QGEN Stock Amid Competition